InvestorsHub Logo
Followers 19
Posts 2188
Boards Moderated 0
Alias Born 08/29/2000

Re: None

Thursday, 02/26/2015 12:57:32 AM

Thursday, February 26, 2015 12:57:32 AM

Post# of 52074
Here is a link to the abstract of the article:
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=9541542&fulltextType=RA&fileId=S0899823X14000361

It seems that the authors were attempting to evaluate independently the claims that Xenex has been making in terms of efficacy, and they conclude that it is limited in certain basic ways, mainly, but not only, as relates to the distance between the instrument and the treated surface.

I wish our guys at Medizone would have taken the time to write an introductory/explanatory paragraph, pointing out the significance of these findings to our potential customers. This article confirms what Dr. Shannon said a long time ago, that AsepticSure is far superior to Xenex, for those very reasons.

Just sending out a table with dry data may be meaningful, but IMO it doesn't carry the impact that it could have.

I hope they'll get the word out somehow to the target community, like hospitals etc.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.